PHLDB3 and cancer: Indeed, our results as shown here demonstrate that PHLDB3 depletion leads to elevated apoptosis (Fig. 4a,b; Supplementary Fig. 2) and increases the sensitivity of cancer cells to therapeutic drugs (Fig. 7c,d; Supplementary Fig. 2).